NEW MJ NEWS

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-2022-earnings-conference-call-301711231.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Biome Grow Inc. (BIO.CN) (BIOIF) announces first shipment of finished product to Newfoundland and Labrador

Biome Grow announces first shipment of finished product to Newfoundland and Labrador…

Cresco Labs (CRLBF) to Report First Quarter 2023 Financial Results on May 24, 2023

Cresco Labs to Report First Quarter 2023 Financial Results on May 24,…

Two Rivers Water & Farming Company (TURV) Announces Additional Capital Infusion

Two Rivers Announces Additional Capital Infusion Two Rivers Water & Farming Company…

$MJNA Patent for World’s First Cannabinoid Release Gum

Photo Release — Patent for World’s First Cannabinoid Release Gum Awarded to…